RecruitingNCT04613388
Registry Study of Proton Radiotherapy in Lymphoma
Multicenter Registry Study on Proton Radiotherapy for Mediastinal Lymphomas
Sponsor
University Hospital Heidelberg
Enrollment
200 participants
Start Date
Aug 1, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Histologically confirmed lymphoma according to WHO
- Patient consent
- Patient age ≥18 years.
- Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).
- Ability of the patient to give consent
Exclusion Criteria3
- Age \<18 years
- Non-consent of the patient to the disclosure of his data
- Cancellation of the patient's participation in the study
Interventions
OTHERAssesment of Effectiveness and side effects
Case Report forms, Quality of life questionaire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04613388